Crossmark

Sofosbuvir plus daclatasvir as an alternative for patients on haemodialysis with genotype 2 hepatitis C virus infection

Crossref DOI link: https://doi.org/10.1016/j.eimc.2017.10.012

Published Print: 2018-08

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Llenas-García, Jara

Padilla, Sergio

Masiá, Mar

Gutiérrez, Félix
License Information

Text and Data Mining valid from 2018-08-01
More Information

This article is maintained by: Elsevier

Article Title: Sofosbuvir plus daclatasvir as an alternative for patients on haemodialysis with genotype 2 hepatitis C virus infection

Journal Title: Enfermedades Infecciosas y Microbiología Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.eimc.2017.10.012

Content Type: simple-article

Copyright: © 2017 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved.